"Altasciences LA is a full-service CRO offering clinical development services to the pharmaceutical, biotechnology, and medical device industries. As a drug development partner, Altasciences LA collaborates with domestic and foreign innovator companies who need regulatory, program management, and strategic consulting support."

During the past decade, WCCT Global conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 37 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 24 clinical trials were completed. i.e. 96% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WCCT Global" #1 sponsor was "Bristol-Myers Squibb" with 18 trials, followed by "Sunovion" with 6 trials sponsored, "Vaxart" with 5 trials sponsored, "AstraZeneca" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WCCT Global" #1 collaborator was "WCCT Global" with 8 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "United States Department of Defense" with 2 trials as a collaborator, "Alpha IRB" with 1 trials as a collaborator and "Analyst Research Laboratories" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "WCCT Global" are "Healthy" (20 trials), "Asthma" (11 trials), "Healthy Volunteers" (9 trials), "Alzheimer's Disease" (4 trials) and "Bleeding" (4 trials). Many other conditions were trialed in "WCCT Global" in a lesser frequency.

Most popular intervention types in "WCCT Global" are "Drug" (129 trials), "Biological" (14 trials), "Other" (11 trials), "Diagnostic Test" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "AC2993" (3 trials), "Itraconazole" (3 trials), "MDT-637" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "WCCT Global" are 133 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "WCCT Global". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 134 completed trials in WCCT Global, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in WCCT Global, 92 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".